United Therapeutics (UTHR) Cash & Equivalents (2009 - 2026)
United Therapeutics (UTHR) posted Cash & Equivalents of $1.8 billion for Q2 2026, up 13.2% from $1.59 billion a year earlier and up 40.9% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, United Therapeutics' Cash & Equivalents came in at $1.56 billion, down 8.3% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
- In prior years, United Therapeutics' Cash & Equivalents was $1.7 billion in FY2024 (+40.5%), $1.21 billion in FY2023 (+25.6%), $961.2 million in FY2022 (+7.4%) and $894.8 million in FY2021 (+21.1%).
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 13.6%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2025, with growth of 51.8%; the weakest was Q1 2026, with a decline of 32.6%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $1.28 billion (Q1 2026), $1.56 billion (Q4 2025) and $1.34 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | United Therapeutics | 24.95 Bn | 15.14 Bn | 733.40 Mn | 1.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.19 Bn |
| Jun 30, 2026 | 1.80 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | 1.56 Bn |
| Sep 30, 2025 | 1.34 Bn |
| Jun 30, 2025 | 1.59 Bn |
| Mar 31, 2025 | 1.90 Bn |
| Dec 31, 2024 | 1.70 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 1.36 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.21 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 961.20 Mn |
| Sep 30, 2022 | 966.80 Mn |
| Jun 30, 2022 | 795.20 Mn |
| Mar 31, 2022 | 813.30 Mn |
| Dec 31, 2021 | 894.80 Mn |
API Access
United Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();